People who have digestive disorders that make it difficult for their bodies to absorb vitamin B12 (such as celiac disease which is more common in people with Down syndrome)
May be administered subcutaneously or intravenously if recommended by a veterinarian
Fat cell targeting is determined by receptor distribution and density throughout the body rather than injection location proximity
This inhibition preserves cellular NAD+ levels by reducing their consumption, simultaneously increasing GLUT4 transporter expression and activating sirtuin 1, known as the "longevity gene." The compound exhibits high membrane permeability and selectivity without affecting related methyltransferases or NAD+ salvage pathway enzymes, creating targeted metabolic effects while maintaining cellular safety
For doses 10 units (0.10 mL), consider 30- or 50-unit insulin syringes for improved readability
While B12 injections do not directly cure FIP, they play a significant role in supporting the immune system and enhancing the cat's response to antiviral therapy
